Recent Visitors
Brian D. Lewis MDBrian D. Lewis MD
David R. Friedland MDDavid R. Friedland MD
Dave Lal MD, MPHDave Lal MD, MPH
Mir Abdul Basir MDMir Abdul Basir MD
Stuart D. Wilson MDStuart D. Wilson MD

CURRICULUM VITAE

Leslie J. Mortland MD
Assistant Professor
Department of Pediatrics
Division of Hematology/Oncology

OFFICE ADDRESS:
MACC Fund Research Center
8701 Watertown Plank Rd
Milwaukee, WI 53226

CITIZENSHIP:  USA

EDUCATION:
8/1997 - 5/2011 BS, Biology, Seton Hall University, South Orange, NJ
1/2002 - 5/2005 MD, Ross University School of Medicine, Portsmouth, Dominica

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
6/2005 - 6/2008 Resident, Pediatrics, University of Florida, Gainesville, FL
7/2008 - 6/2011 Fellow, Pediatrics, Hematology, Oncology, BMT, University of Minnesota, Minneapolis, MN

FACULTY APPOINTMENTS:
8/1/2011 - Present Assistant Professor, Pediatrics, Hematology, Oncology, BMT, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
8/1/2011 - Present Children's Hospital of Wisconsin, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
General Pediatrics
10/27/2008
None
 
AWARDS AND HONORS:
1997 - 2001 Academic and Athletic Scholarship Recipient, Seton Hall University
1997 - 2001 Big East Conference All-Academic Team, Seton Hall University
2002 - 2005 Dean’s List, Ross University School of Medicine

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
Children's Oncology Group (COG)
American Society of Hematology (ASH)
American Society of Pediatric Hematology and Oncology (ASPHO)
American Society of Clinical Oncology (ASCO)

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Non-Peer Review
Title:
Prospective Evaluation of Bone Mineral Density in Pediatric Osteosarcoma and Ewing's Sarcoma: Evaluation of a Novel Screening Tool
Source:
MACC Fund
Role:
Prinicipal Investigator
PI:
Leslie Mortland
Dates:
1/1/2013 - Present
 
INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
National
1. Leslie Mortland, Amit Mitra, Soheil Meshinchi, Roland Walter, Todd Alonzo, Robert Gerbing, and Jatinder Lamba, Clinical Significance of CD33 Non-synonymous single nucleotide polymorphisms (SNPs) in pediatric acute myeloid leukemia treated with gemtuzumab ozogamicin-containing chemotherapy, ASH 2011 Abstract Poster Presentation, 12/1/2011 - Present
 
MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
8/1/2011 - Present Medical Student Clinical Pathway Mentor
 
COMMUNITY SERVICE ACTIVITIES:
2002 - 2005 American Medical Student Association
2005 - 2008 Habitat for Humanity


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Mortland L, Alonzo T, Walter B, et al. Clinical significance of CD33 non-synonymous single nucleotide polymorphisms (SNPS) in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapy. Clin Cancer Res. 2013 Mar 15; 19:1620-1627.
2. Browning M, Mortland L & Malogolowkin M. Chemotherapy in pediatric bone and soft-tissue sarcomas. Current Orthopaedic Practice. [Accepted for publication April 2013]